Editas Medicine (EDIT)
(Delayed Data from NSDQ)
$1.22 USD
-0.02 (-1.61%)
Updated Jan 17, 2025 04:00 PM ET
After-Market: $1.21 -0.01 (-0.82%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 2/26/25 |
---|---|
Current Quarter | -0.42 |
EPS Last Quarter | -0.75 |
Last EPS Surprise | 1.32% |
ABR | 2.67 |
Earnings ESP
|
71.13% |
---|---|
Current Year | -2.73 |
Next Year | -1.82 |
EPS (TTM) | -2.56 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 34.91M | 1.23M | 42.59M | 8.52M |
# of Estimates | 5 | 3 | 6 | 6 |
High Estimate | 57.10M | 1.70M | 72.40M | 27.80M |
Low Estimate | 0.11M | 1.00M | 1.82M | 2.73M |
Year ago Sales | 60.05M | 1.14M | 78.12M | 42.59M |
Year over Year Growth Est. | -41.86% | 8.16% | -45.49% | -79.99% |
Earnings Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.42 | -0.59 | -2.73 | -1.82 |
# of Estimates | 7 | 3 | 9 | 8 |
Most Recent Consensus | -0.70 | NA | -3.03 | -2.93 |
High Estimate | -0.01 | -0.51 | -2.33 | -1.05 |
Low Estimate | -0.86 | -0.74 | -3.18 | -3.31 |
Year ago EPS | -0.23 | -0.76 | -2.02 | -2.73 |
Year over Year Growth Est. | -82.61% | 22.37% | -35.15% | 33.64% |
Agreement - Estimate Revisions
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 0 | 1 | 0 |
Up Last 60 Days | 3 | 1 | 3 | 5 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 2 |
Down Last 60 Days | 1 | 0 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.42 | -0.59 | -2.73 | -1.82 |
7 Days Ago | -0.42 | -0.59 | -2.73 | -1.82 |
30 Days Ago | -0.29 | -0.50 | -2.63 | -1.61 |
60 Days Ago | -0.36 | -0.65 | -2.70 | -2.24 |
90 Days Ago | -0.67 | -0.68 | -2.98 | -2.83 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.12 | -0.59 | -2.42 | -2.06 |
Zacks Consensus Estimate | -0.42 | -0.59 | -2.73 | -1.82 |
Earnings ESP | 71.13% | 0.00% | 11.46% | -13.50% |
Surprise - Reported Earnings History
Quarter Ending (9/2024) |
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.75 | -0.82 | -0.76 | -0.23 | NA |
Estimate | -0.76 | -0.69 | -0.63 | -0.52 | NA |
Difference | 0.01 | -0.13 | -0.13 | 0.29 | 0.01 |
Surprise | 1.32% | -18.84% | -20.63% | 55.77% | 4.41% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more